(Q38086009)

28 August 2017

Roles of microRNAs during prostatic tumorigenesis and tumor progression (English)

1 reference

28 August 2017

1 reference

1 reference

Y-X Fang

1

1 reference

28 August 2017

W-Q Gao

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

4 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

33

1 reference

28 August 2017

135-147

1 reference

28 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.54

28 August 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

BCL-2 in prostate cancer: a minireview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Gene regulation by transcription factors and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNAs in cancer: small molecules with a huge impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA sequence and expression analysis in breast tumors by deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Clinical significance of miR-146a in gastric cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a Pten-deficient mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Androgen regulation of micro-RNAs in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Widespread deregulation of microRNA expression in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Lin28 promotes transformation and is associated with advanced human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Selective blockade of microRNA processing by Lin28

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Impaired microRNA processing enhances cellular transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Identification of novel microRNA targets based on microRNA signatures in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNAs associated with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-205 regulates basement membrane deposition in human prostate: implications for cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Evidence linking CD44-positive cells and gemcitabine resistance in pancreatic cancer cells: need for further substantiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The functional significance of microRNA-145 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Fascin expression in endocervical neoplasia: correlation with tumour morphology and growth pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Androgen receptor structural and functional elements: role and regulation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Mechanisms mediating androgen receptor reactivation after castration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-21: an oncomir on strike in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Identification of a cell of origin for human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Basal epithelial stem cells are efficient targets for prostate cancer initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Role of thrombin as a tumor growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The expression and clinical significance of GTP-binding RAS-like 3 (ARHI) and microRNA 221 and 222 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNAs and their potential for translation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Cancer stem cells: models and concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA regulation of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

let-7 microRNAs in development, stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

The role of microRNA-145 in human embryonic stem cell differentiation into vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Human amniotic epithelial cell feeder layers maintain human iPS cell pluripotency via inhibited endogenous microRNA-145 and increased Sox2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miRNA-708 control of CD44(+) prostate cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Circulating microRNAs: potential biomarkers for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Changes in circulating microRNA levels associated with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Improvement of prostate cancer detection by integrating the PSA test with miRNA expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Identification of Drosophila MicroRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

microRNA dysregulation in prostate cancer: network analysis reveals preferential regulation of highly connected nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Stem Cells and Cancer: Two Faces of Eve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA profile analysis of human prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Galpha(q) and phospholipase C-beta: turn on, turn off, and do it fast.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Circulating miRNAs are correlated with tumor progression in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.54

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.54

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference